Discover 1,107 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,107
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Boston MA, Providence RI, Stony Brook NY, Sherbrooke,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase3, Recruiting
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
for
Breast Cancer, Metastatic Breast Cancer
Location: Chapel Hill NC, Birmingham AL
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06855654
Recruiting
Prevail Global Study
for
Coronary Artery Disease
Location: Providence RI, Roslyn NY, New York NY, Paramus NJ,
Sponsor: Medtronic Vascular
Sex: All
Age: 18+
Code: NCT06535854
Recruiting
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Boston MA, Cooper City FL, Miami FL, West Columbia SC,
Sponsor: Origin Inc.
Sex: All
Age: 22 - 70+
Code: NCT03078933
Recruiting
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
for
Persistent Corneal Epithelial Defect
Location: Palisades Park NJ, Bala-Cynwyd PA, South Miami FL,
Sponsor: Glaukos Corporation
Sex: All
Age: 2+
Code: NCT05966493
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth
for
HIV
Location: Birmingham AL
Sponsor: Wayne State University
Sex: All
Age: 16 - 24
Code: NCT01969461
Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
for
Degenerative Disc Disease (DDD)
Location: Richmond VA, West Palm Beach FL, Port Charlotte FL,
Sponsor: ReGelTec, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06011551
Recruiting
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
for
Non-Small Cell Lung Cancer
Location: Boston MA, Stuart FL, Birmingham AL, Nashville TN
Sponsor: Precision Therapeutics
Sex: All
Age: 18+
Code: NCT01450553
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
for
Solid Malignancies
Location: Dothan AL, Houston TX, Palo Alto CA
Sponsor: Immunome, Inc.
Sex: All
Age: 18+
Code: NCT07505771
Phase1, Recruiting
Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
for
Hair Thinning
Location: Aventura FL, Birmingham AL
Sponsor: The Center for Clinical and Cosmetic Research
Sex: Female
Age: 28 - 65
Code: NCT07041489
Recruiting
Study of NTB-928 in R/R OC
for
Relapsed/Refractory Ovarian Carcinoma
Location: Lake Success NY, Birmingham AL, Omaha NE, Fort Worth TX
Sponsor: TeneoSeven, Inc.
Sex: Female
Age: 18+
Code: NCT07690189
Phase1, Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
for
Moderate-to-Severe Atopic Dermatitis
Location: The Bronx NY, Robbinsville NJ, Tamarac FL, Savannah GA,
Sponsor: Nektar Therapeutics
Sex: All
Age: 12+
Code: NCT07711418
Phase3, Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, Miami FL, DuBois PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase3, Recruiting
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
for
Invasive Mould Infection
Location: Boston MA, Baltimore MD, Toronto, Hamilton, Augusta GA,
Sponsor: Elion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07215273
Phase2, Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for
Multiple Sclerosis
Location: Teaneck NJ, Baltimore MD, Raleigh NC,
Sponsor: Sanofi
Sex: All
Age: 18 - 60
Code: NCT07325292
Phase3, Recruiting
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
for
Urge Urinary Incontinence
Location: Philadelphia PA, Allentown PA, Charleston SC,
Sponsor: MedtronicNeuro
Sex: All
Age: 18+
Code: NCT07456865
Recruiting
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
for
Glaucoma
Location: Dothan AL
Sponsor: Glaukos Corporation
Sex: All
Age: 18+
Code: NCT07495852
Phase3, Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: East Setauket NY, Stamford CT, Baltimore MD,